NASD · Healthcare · Medical Devices · Israel
Brainsway Ltd ADR is a small cap company (market value between $300 million and $2 billion) in the Medical Devices industry.
Intrinsic value, DCF valuation, financial health and value investing analysis for the Brainsway Ltd ADR stock.
Overvalued: intrinsic value $5.46 per share, market price $11.36, margin of safety -108.2% (as of 2026-10-30).
Discounting its cash flows at 11.1% (average of 3 methods) values the shares at $5.46; the price of $11.36 is 108% above that value, and 71% of that value comes from beyond year five.
Leak Score: 39/100 on 10 of 12 signals (On Watch).
All 142 Medical Devices stocks
39 more in this industry show a wider margin of safety.
BWAY is overvalued (as of the 2026-10-30 close). Discounting its cash flows at 11.1% (average of 3 methods) values the shares at $5.46; the price of $11.36 is 108% above that value, and 71% of that value comes from beyond year five.
$5.46 per share (as of the 2026-10-30 close), against a market price of $11.36. That is a margin of safety of -108.2%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
39 out of 100, which we rate "On Watch", on 10 of 12 value investing signals.